NBO Pharma

Bedford, United States

NBO Pharma is a biotechnology company that develops drug for the treatment of Idiopathic Intracranial Hypertension.

$7.6M raised

Jan 2026

Seed

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NBO Pharma

How much funding has NBO Pharma raised?

NBO Pharma has raised $7.6M in total funding. The most recent round was Seed. The last funding was announced in January 2026.

Where is NBO Pharma headquartered?

NBO Pharma is headquartered in Bedford, United States.

What does NBO Pharma do?

NBO Pharma is a biotechnology company that develops drug for the treatment of Idiopathic Intracranial Hypertension.

What stage is NBO Pharma at?

NBO Pharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 22, 2026.

MLA

"NBO Pharma — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/nbo-pharma. Accessed June 3, 2026.

APA

VCBacked. (2026). NBO Pharma — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/nbo-pharma

Wikipedia (cite web)

{{cite web |title=NBO Pharma — Funding & Investors |url=https://www.vcbacked.co/company/nbo-pharma |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 22, 2026.